Pathologists at McGovern Medical School at UTHealth have developed a chemically modified protein that may help people with a hard-to-treat form of a genetic bleeding disorder known as Hemophilia A. The discovery and the results of pre-clinical tests appear in the May 2008 issue of the Journal of Biological Chemistry.